What is the best oral antibiotic for a Coagulase-negative Staphylococcus (CoNS) urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Antibiotic Treatment for Coagulase-Negative Staphylococcus UTI

For coagulase-negative staphylococcus (CoNS) urinary tract infections, trimethoprim-sulfamethoxazole (TMP-SMX) or a fluoroquinolone (ciprofloxacin or levofloxacin) are the preferred oral antibiotics, with treatment duration of 5-7 days if uncomplicated. 1

Treatment Approach

First-Line Oral Options

  • TMP-SMX is a reasonable first-line choice for CoNS UTI, particularly when local resistance rates are acceptable (<10-20%) 1
  • Fluoroquinolones (ciprofloxacin 500 mg twice daily or levofloxacin 750 mg once daily) are highly effective alternatives with excellent urinary concentrations and activity against CoNS 2, 3, 4
  • Nitrofurantoin (5 days) can be considered for uncomplicated cystitis due to CoNS, though data are more limited for staphylococcal species compared to gram-negative organisms 1, 5

Treatment Duration

  • 5-7 days is appropriate for uncomplicated CoNS UTI with catheter removal 1
  • 10-14 days may be warranted if the catheter remains in place or if there are complicating factors 1
  • For catheter-associated infections, replace the catheter if it has been in place ≥2 weeks before initiating antimicrobial therapy to improve outcomes 1

Key Clinical Considerations

Fluoroquinolone Use

  • Ciprofloxacin and levofloxacin achieve excellent urinary concentrations that exceed the minimum inhibitory concentrations for CoNS throughout the dosing interval 3, 6
  • However, fluoroquinolones should be reserved for situations where other options are unsuitable due to concerns about collateral damage, C. difficile risk, and antimicrobial stewardship 1
  • The FDA has issued warnings against fluoroquinolone use for uncomplicated UTIs due to unfavorable risk-benefit ratios 1

Alternative Considerations

  • Cephalexin (first-generation cephalosporin) may be used but has higher rates of recurrence and collateral damage compared to nitrofurantoin 1
  • Fosfomycin (single 3-g dose) is an option for uncomplicated cystitis, though evidence specifically for CoNS is limited 1, 5

Important Caveats

  • Always obtain urine culture before initiating therapy to confirm CoNS as the causative pathogen and guide definitive treatment based on susceptibilities 1
  • CoNS are the most common cause of catheter-related infections and typically have a benign clinical course 1
  • Staphylococcus lugdunensis is an exception among CoNS species and should be treated more aggressively, similar to S. aureus infections 1
  • If the patient is asymptomatic with CoNS bacteriuria and no systemic signs, observation without antibiotics may be appropriate after catheter removal, with repeat cultures to confirm clearance 1

Catheter Management

  • For catheter-associated CoNS UTI, catheter removal is critical whenever possible 1
  • If the catheter must remain, consider antibiotic lock therapy (vancomycin 5 mg/mL) in combination with systemic antibiotics for 10-14 days 1
  • Obtain urine specimens from a freshly placed catheter rather than from an established biofilm-colonized catheter for accurate culture results 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.